APP13007 (Clobetasol Propionate Ophthalmic Nanosuspension) for the Treatment of Inflammation and Pain after Cataract Surgery

被引：0
|
作者：
Levenson, Jeffrey [1 ]
Walters, Thomas R. [2 ]
Martel, Joseph [3 ]
Wang, Laurene [4 ]
Nunez, Derek [4 ]
机构：
[1] Levenson Eye Associates, Jacksonville, FL USA
[2] Keystone Res, Austin, TX USA
[3] Martel Eye Med Grp, Rancho Cordova, CA USA
[4] AimMax Therapeut Inc, Durham, NC USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2022年 / 63卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
F0131
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Efficacy and safety of Clobetasol propionate ophthalmic nanoemulsion, 0.05% for the treatment of intraocular inflammation and pain associated with cataract surgery
    Schwartz, Andrew
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [2] Clobetasol propionate for post-cataract surgery pain and inflammation
    Azhar, Syeda D.
    Shahid, Nayab
    Sadiq, Aiman
    Khan, Aimen W.
    Sultan Dar, Marrium
    Fadlalla Ahmed, Tagwa K.
    ANNALS OF MEDICINE AND SURGERY, 2024, 86 (11): : 6395 - 6398
  • [3] Submicron loteprednol etabonate ophthalmic gel 0.38% for the treatment of inflammation and pain after cataract surgery
    Fong, Raymond
    Silverstein, Bruce E.
    Peace, James H.
    Williams, Jon, I
    Vittitow, Jason L.
    JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2018, 44 (10): : 1220 - 1229
  • [4] Critical appraisal of ophthalmic ketorolac in treatment of pain and inflammation following cataract surgery
    Reddy, Rahul
    Kim, Stephen Jae
    CLINICAL OPHTHALMOLOGY, 2011, 5 : 751 - 758
  • [5] Safety and efficacy of loteprednol etabonate ophthalmic ointment 0.5% for the treatment of inflammation and pain following cataract surgery
    Comstock, Timothy L.
    Paterno, Michael R.
    Singh, Angele
    Erb, Tara
    Davis, Elizabeth
    CLINICAL OPHTHALMOLOGY, 2011, 5 : 177 - 186
  • [6] Nepafenac: An Ophthalmic Nonsteroidal Antiinflammatory Drug for Pain After Cataract Surgery
    Jones, Benjamin M.
    Neville, Michael W.
    ANNALS OF PHARMACOTHERAPY, 2013, 47 (06) : 892 - 896
  • [7] Management of ocular inflammation and pain following cataract surgery: focus on bromfenac ophthalmic solution
    Cho, Hyung
    Wolf, Kenneth J.
    Wolf, Eric J.
    CLINICAL OPHTHALMOLOGY, 2009, 3 : 199 - 210
  • [8] Sustained-release dexamethasone for the treatment of ocular inflammation and pain after cataract surgery
    Walters, Thomas
    Endl, Michael
    Elmer, Thomas R.
    Levenson, Jeffrey
    Majmudar, Parag
    Masket, Samuel
    JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2015, 41 (10): : 2049 - 2059
  • [9] Topical ketorolac tromethamine 0.5% ophthalmic solution in ocular inflammation after cataract surgery
    Solomon, KD
    Cheetham, JK
    DeGryse, R
    Brint, SF
    Rosenthal, A
    OPHTHALMOLOGY, 2001, 108 (02) : 331 - 337
  • [10] Nepafenac ophthalmic suspension 0.1% for the prevention and treatment of ocular inflammation associated with cataract surgery
    Lane, Stephen S.
    Modi, Satish S.
    Lehmann, Robert P.
    Holland, Edward J.
    JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2007, 33 (01): : 53 - 58
12345